Detalhe da pesquisa
1.
The environmental impact of inhaled therapy: making informed treatment choices.
Eur Respir J
; 60(1)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916263
2.
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.
N Engl J Med
; 372(21): 1987-95, 2015 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981191
3.
How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
Am J Respir Crit Care Med
; 196(2): 139-149, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27922741
4.
Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD.
Pulm Pharmacol Ther
; 31: 68-78, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25727846
5.
Minimal clinically important differences in pharmacological trials.
Am J Respir Crit Care Med
; 189(3): 250-5, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24383418
6.
Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
N Engl J Med
; 364(12): 1093-1103, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21428765
7.
Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.
BMC Pulm Med
; 14: 209, 2014 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25539654
8.
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.
Respir Res
; 14: 116, 2013 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24168767
9.
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.
Int J Chron Obstruct Pulmon Dis
; 17: 2745-2755, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317185
10.
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes.
Pragmat Obs Res
; 12: 25-35, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079422
11.
Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
Adv Ther
; 26(7): 691-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19609496
12.
Is there a role for antiinflammatory treatment in COPD?
COPD
; 6(5): 395-403, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19863369
13.
Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT).
Int J Chron Obstruct Pulmon Dis
; 13: 1701-1711, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29872288
14.
ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD.
Int J Chron Obstruct Pulmon Dis
; 12: 2545-2558, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28883722
15.
The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease.
Tuberc Respir Dis (Seoul)
; 79(4): 241-247, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27790275
16.
Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
Int J Chron Obstruct Pulmon Dis
; 11: 1425-34, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27418815
17.
Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®).
Adv Ther
; 32(6): 537-47, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100349
18.
Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD.
Chest
; 123(3): 778-83, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12628878
19.
Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4.
Chest
; 123(4): 1240-7, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12684317
20.
And Then There Were Three: Time to Move Onward in COPD Drug Development Beyond LAMA/LABA/ICS at Last?
Pulm Ther
; 4(2): 115-119, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32026390